Linzonol 600 mg contains Linezolid, a synthetic antibiotic that inhibits bacterial protein synthesis. By targeting the bacterial ribosome, Linezolid prevents the formation of functional 70S initiation complexes, leading to bacterial cell death. This mechanism of action makes Linzonol 600 mg effective against a wide range of bacterial infections, including those caused by multidrug-resistant strains. With its broad-spectrum activity and excellent tissue penetration, Linzonol 600 mg ensures comprehensive treatment and swift recovery.